Protide Pharmaceuticals, Inc. Stock Other OTC

PPMD

US74371A1034

Biotechnology & Medical Research

OTC Markets Traded

Latest news : Protide Pharmaceuticals, Inc.

25/09/13

Protide Pharmaceuticals Inc. Announces Introduction of 2-8 CELLsius

More news

Managers and Directors: Protide Pharmaceuticals, Inc.

Manager	Title	Age	Since
Milo R. Polovina CEO	Chief Executive Officer	70	-

Director	Title	Age	Since
Milo R. Polovina CHM	Chairman	70	18/02/2010

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PROTIDE PHARMACEUTICALS, INC.	-75.00%	-75.00%	-	-	886K
LONZA GROUP AG	+0.68%	-2.28%	+2.16%	+19.70%	48.42B
REVOLUTION MEDICINES, INC.	+4.07%	+2.43%	+483.70%	+623.80%	43.66B
BEONE MEDICINES AG	+4.33%	+0.98%	+12.80%	+88.53%	39.51B
IQVIA HOLDINGS INC.	+1.94%	-0.31%	+26.24%	+12.62%	38.95B
CELLTRION, INC.	-0.50%	+0.85%	+20.60%	+58.18%	32.61B
ASCENDIS PHARMA A/S	-0.44%	-3.22%	-	-	16.32B
MEDPACE HOLDINGS, INC.	+3.22%	-0.88%	+30.42%	+135.47%	16.15B
EUROFINS SCIENTIFIC SE	-0.62%	-0.06%	+3.46%	+27.74%	14.16B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+2.35%	+3.48%	+82.95%	+43.41%	13.37B
Average	-6.00%	+0.02%	+82.79%	+126.18%	29.24B
Weighted average by Cap.	+1.93%	+0.04%	+101.58%	+150.86%

See all sector performances

Protide Pharmaceuticals, Inc. is engaged in the discovery, development and advancement of technologies and processes in clinical cell therapy, regenerative medicine, transplantation and cell engineering. The Company offers a range of products, including serum replacements, cryopreservatives, cell processing and cell islet transplantation (CIT) islet cell solutions. The Company's serum replacements product enables insight into cellular processes, as well as commercial production of recombinant therapeutic proteins, vaccines and other biological proteins. Its serum replacements product includes TCH, VaxMax, HemaPro, TM-235 and TCM. Its cryopreservatives products include Stemsol USP (DMSO), pZerve, Cellvation, MiCord 55% DMSO USP 5% Dextran USP and 2-8CELLsius + DMSO. Its cell processing products include 2-8CELLsius, Dextran 40 in 0.9% NaCl, Dulbecco's Phosphate Buffered Saline (10X) PBS, Dulbecco's Phosphate Buffered Saline (1X) PBS and Hank's Balanced Salt Solution (1X) HBSS.

Employees

Sector

Biotechnology & Medical Research

More about the company